Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) EBIAT: 2020-2021

Historic EBIAT for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$11.5 million.

  • Bright Minds Biosciences' EBIAT fell 3895.34% to -$11.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$6.8 million, marking a year-over-year change of. This contributed to the annual value of -$6.8 million for FY2021, which is 2015.22% down from last year.
  • According to the latest figures from Q3 2021, Bright Minds Biosciences' EBIAT is -$11.5 million, which was down 498.91% from $2.9 million recorded in Q2 2021.
  • Bright Minds Biosciences' 5-year EBIAT high stood at $2.9 million for Q2 2021, and its period low was -$11.5 million during Q3 2021.
  • In the last 2 years, Bright Minds Biosciences' EBIAT had a median value of $519,340 in 2020 and averaged -$1.3 million.
  • Data for Bright Minds Biosciences' EBIAT shows a maximum YoY plummeted of 3,895.34% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Bright Minds Biosciences' EBIAT stood at $519,340 in 2020, then slumped by 3,895.34% to -$11.5 million in 2021.
  • Its last three reported values are -$11.5 million in Q3 2021, $2.9 million for Q2 2021, and $1.3 million during Q1 2021.